Analysis

Cabaletta Bio is a late-stage clinical biotechnology company focused on developing targeted cell therapies specifically for patients with autoimmune diseases.…

Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company focused on infectious diseases. For the year ended December 31, 2025, Arbutus…

Sutro Biopharma is a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs). For the year ended December…

Talphera is a specialty pharmaceutical company developing therapies for medically supervised settings. They are currently advancing their lead product candidate,…

Context Therapeutics is a clinical-stage biopharmaceutical company developing T cell engaging bispecific antibodies for solid tumors. The company reported a…

Lithium Argentina produces lithium carbonate primarily for the electric vehicle and battery markets. The company operates and holds a 44.8%…

AGI is a profitable fintech providing financial services to underserved Brazilians. It operates a hybrid business model combining digital platforms…

March 20, 2026 — NVIDIA is positioning for a return to China's AI accelerator market after the U.S. Bureau of…

March 20, 2026 — Qualcomm's board approved a new $20 billion stock repurchase authorization and raised its quarterly cash dividend…

Xunlei's Q4 adjusted EPS of $0.08 matched the prior quarter as revenue stalled at $143.3M, raising concerns about growth trajectory.